- Sections :
- Crime & Public Safety
- Restaurants & Food
- Sports
- More
Categories
THE WOODLANDS, Texas -- On Monday, March 8, Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced plans to sell $95 million of its common stock in a public offering. Lexicon also announced plans to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
All of the shares in the offering will be sold by Lexicon. Morgan Stanley & Co. Incorporated and J.P. Morgan Securities Inc. will be acting as joint book-runners for the offering, with Cowen and Company, LLC and Thomas Weisel Partners LLC acting as co-managers.
Source: Lexicon Pharmaceuticals, Inc.
All of the shares in the offering will be sold by Lexicon. Morgan Stanley & Co. Incorporated and J.P. Morgan Securities Inc. will be acting as joint book-runners for the offering, with Cowen and Company, LLC and Thomas Weisel Partners LLC acting as co-managers.
Source: Lexicon Pharmaceuticals, Inc.
Comments •
Related News: Business
